{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:44:19Z","timestamp":1795113859248,"version":"4.10.3"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82102705, No. U19A2008, No. U19A2008, No.82272787, No.82373232, No.82473189, No.82303259"],"award-info":[{"award-number":["No.82102705, No. U19A2008, No. U19A2008, No.82272787, No.82373232, No.82473189, No.82303259"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-58429-7","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T21:16:53Z","timestamp":1743801413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Cholangiocarcinoma PDHA1 succinylation suppresses macrophage antigen presentation via alpha-ketoglutaric acid accumulation"],"prefix":"10.1038","volume":"16","author":[{"given":"Ning","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linmao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianming","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiareng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuetian","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingrui","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhui","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4578-3817","authenticated-orcid":false,"given":"Jiabei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0365-3229","authenticated-orcid":false,"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3535-6467","authenticated-orcid":false,"given":"Lianxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"58429_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley, P. J. et al. Cholangiocarcinoma. Nat. Rev. Dis. Prim. 7, 65 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"58429_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/liv.14101","volume":"39","author":"JM Banales","year":"2019","unstructured":"Banales, J. M. et al. Cholangiocarcinoma: state-of-the-art knowledge and challenges. Liver Int. 39, 5\u20136 (2019).","journal-title":"Liver Int."},{"key":"58429_CR3","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle, J. et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N. Engl. J. Med. 362, 1273\u20131281 (2010).","journal-title":"N. Engl. J. Med."},{"key":"58429_CR4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/sj.bjc.6605779","volume":"103","author":"T Okusaka","year":"2010","unstructured":"Okusaka, T. et al. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br. J. Cancer 103, 469\u2013474 (2010).","journal-title":"Br. J. Cancer"},{"key":"58429_CR5","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41392-021-00825-8","volume":"6","author":"W Li","year":"2021","unstructured":"Li, W., Li, F., Zhang, X., Lin, H. K. & Xu, C. Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment. Signal Transduct. Target Ther. 6, 422 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"58429_CR6","doi-asserted-by":"crossref","unstructured":"Faubert, B., Solmonson, A. & DeBerardinis, R. J. Metabolic reprogramming and cancer progression. Science 368, eaaw5473 (2020).","DOI":"10.1126\/science.aaw5473"},{"key":"58429_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s00018-023-05104-z","volume":"81","author":"H Shi","year":"2024","unstructured":"Shi, H. et al. A glimpse into novel acylations and their emerging role in regulating cancer metastasis. Cell Mol. Life Sci. 81, 76 (2024).","journal-title":"Cell Mol. Life Sci."},{"key":"58429_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nchembio.495","volume":"7","author":"Z Zhang","year":"2011","unstructured":"Zhang, Z. et al. Identification of lysine succinylation as a new post-translational modification. Nat. Chem. Biol. 7, 58\u201363 (2011).","journal-title":"Nat. Chem. Biol."},{"key":"58429_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cmet.2018.01.016","volume":"27","author":"C Carrico","year":"2018","unstructured":"Carrico, C., Meyer, J. G., He, W., Gibson, B. W. & Verdin, E. The mitochondrial acylome emerges: proteomics, regulation by sirtuins, and metabolic and disease implications. Cell Metab. 27, 497\u2013512 (2018).","journal-title":"Cell Metab."},{"key":"58429_CR10","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2013.11.013","volume":"18","author":"MJ Rardin","year":"2013","unstructured":"Rardin, M. J. et al. SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. Cell Metab. 18, 920\u2013933 (2013).","journal-title":"Cell Metab."},{"key":"58429_CR11","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1158\/0008-5472.CAN-17-1912","volume":"78","author":"X Yang","year":"2018","unstructured":"Yang, X. et al. SHMT2 desuccinylation by SIRT5 drives cancer cell proliferation. Cancer Res. 78, 372\u2013386 (2018).","journal-title":"Cancer Res."},{"key":"58429_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303535","volume":"10","author":"Q Hu","year":"2023","unstructured":"Hu, Q. et al. SUCLG2 regulates mitochondrial dysfunction through succinylation in lung adenocarcinoma. Adv. Sci. 10, e2303535 (2023).","journal-title":"Adv. Sci."},{"key":"58429_CR13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13046-020-01681-0","volume":"39","author":"X Li","year":"2020","unstructured":"Li, X. et al. Lysine-222 succinylation reduces lysosomal degradation of lactate dehydrogenase a and is increased in gastric cancer. J. Exp. Clin. Cancer Res. 39, 172 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"58429_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature12154","volume":"498","author":"J Kaplon","year":"2013","unstructured":"Kaplon, J. et al. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature 498, 109\u2013112 (2013).","journal-title":"Nature"},{"key":"58429_CR15","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.cmet.2021.07.016","volume":"33","author":"S Jun","year":"2021","unstructured":"Jun, S. et al. The requirement for pyruvate dehydrogenase in leukemogenesis depends on cell lineage. Cell Metab. 33, 1777\u20131792.e1778 (2021).","journal-title":"Cell Metab."},{"key":"58429_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41588-017-0026-3","volume":"50","author":"J Chen","year":"2018","unstructured":"Chen, J. et al. Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer. Nat. Genet. 50, 219\u2013228 (2018).","journal-title":"Nat. Genet."},{"key":"58429_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2016.35","volume":"2","author":"S Xu","year":"2017","unstructured":"Xu, S. et al. Butyrate induces apoptosis by activating PDC and inhibiting complex I through SIRT3 inactivation. Signal Transduct. Target. Ther. 2, 16035 (2017).","journal-title":"Signal Transduct. Target. Ther."},{"key":"58429_CR18","doi-asserted-by":"publisher","first-page":"738916","DOI":"10.3389\/fcell.2021.738916","volume":"9","author":"B Cevatemre","year":"2021","unstructured":"Cevatemre, B., Ulukaya, E., Dere, E., Dilege, S. & Acilan, C. Pyruvate dehydrogenase contributes to drug resistance of lung cancer cells through epithelial mesenchymal transition. Front. Cell Dev. Biol. 9, 738916 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"58429_CR19","doi-asserted-by":"publisher","first-page":"947372","DOI":"10.3389\/fphar.2022.947372","volume":"13","author":"L Deng","year":"2022","unstructured":"Deng, L., Jiang, A., Zeng, H., Peng, X. & Song, L. Comprehensive analyses of PDHA1 that serves as a predictive biomarker for immunotherapy response in cancer. Front. Pharmacol. 13, 947372 (2022).","journal-title":"Front. Pharmacol."},{"key":"58429_CR20","doi-asserted-by":"publisher","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis, R. J. & Chandel, N. S. Fundamentals of cancer metabolism. Sci. Adv. 2, e1600200 (2016).","journal-title":"Sci. Adv."},{"key":"58429_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.molcel.2019.10.023","volume":"77","author":"JY Wu","year":"2020","unstructured":"Wu, J. Y. et al. Cancer-derived succinate promotes macrophage polarization and cancer metastasis via succinate receptor. Mol. Cell 77, 213\u2013227.e215 (2020).","journal-title":"Mol. Cell"},{"key":"58429_CR22","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.cmet.2023.04.017","volume":"35","author":"J Cheng","year":"2023","unstructured":"Cheng, J. et al. Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8(+) T cells in the tumor microenvironment. Cell Metab. 35, 961\u2013978.e910 (2023).","journal-title":"Cell Metab."},{"key":"58429_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/SHK.0000000000001333","volume":"53","author":"M Liu","year":"2020","unstructured":"Liu, M. et al. \u03b1-Ketoglutarate modulates macrophage polarization through regulation of PPAR\u03b3 transcription and mTORC1\/p70S6K pathway to ameliorate ALI\/ARDS. Shock 53, 103\u2013113 (2020).","journal-title":"Shock"},{"key":"58429_CR24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cmet.2016.06.004","volume":"24","author":"V Lampropoulou","year":"2016","unstructured":"Lampropoulou, V. et al. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab. 24, 158\u2013166 (2016).","journal-title":"Cell Metab."},{"key":"58429_CR25","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fimmu.2014.00614","volume":"5","author":"N Wang","year":"2014","unstructured":"Wang, N., Liang, H. & Zen, K. Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front. Immunol. 5, 614 (2014).","journal-title":"Front. Immunol."},{"key":"58429_CR26","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s12013-013-9750-1","volume":"68","author":"M Akram","year":"2014","unstructured":"Akram, M. Citric acid cycle and role of its intermediates in metabolism. Cell Biochem. Biophys. 68, 475\u2013478 (2014).","journal-title":"Cell Biochem. Biophys."},{"key":"58429_CR27","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/ni.3704","volume":"18","author":"EL Mills","year":"2017","unstructured":"Mills, E. L., Kelly, B. & O\u2019Neill, L. A. J. Mitochondria are the powerhouses of immunity. Nat. Immunol. 18, 488\u2013498 (2017).","journal-title":"Nat. Immunol."},{"key":"58429_CR28","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.bbabio.2014.03.013","volume":"1837","author":"P B\u00e9nit","year":"2014","unstructured":"B\u00e9nit, P. et al. Unsuspected task for an old team: succinate, fumarate and other Krebs cycle acids in metabolic remodeling. Biochim. Biophys. Acta 1837, 1330\u20131337 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"58429_CR29","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2013.04.005","volume":"38","author":"EL Pearce","year":"2013","unstructured":"Pearce, E. L. & Pearce, E. J. Metabolic pathways in immune cell activation and quiescence. Immunity 38, 633\u2013643 (2013).","journal-title":"Immunity"},{"key":"58429_CR30","doi-asserted-by":"crossref","unstructured":"Li, M. et al. \u03b1-Ketoglutaric acid reprograms macrophages by altering energy metabolism to promote the regeneration of small-diameter vascular grafts. ACS Biomater. Sci. Eng. 11, 518\u2013530 (2025).","DOI":"10.1021\/acsbiomaterials.4c01702"},{"key":"58429_CR31","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/omi.12241","volume":"33","author":"S Yu","year":"2018","unstructured":"Yu, S., Ding, L., Liang, D. & Luo, L. Porphyromonas gingivalis inhibits M2 activation of macrophages by suppressing \u03b1-ketoglutarate production in mice. Mol. Oral. Microbiol 33, 388\u2013395 (2018).","journal-title":"Mol. Oral. Microbiol"},{"key":"58429_CR32","doi-asserted-by":"crossref","unstructured":"Liu, Z., Gan, L., Zhang, T., Ren, Q. & Sun, C. Melatonin alleviates adipose inflammation through elevating \u03b1-ketoglutarate and diverting adipose-derived exosomes to macrophages in mice. J. Pineal Res. 64, e12455 (2018).","DOI":"10.1111\/jpi.12455"},{"key":"58429_CR33","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/gutjnl-2021-326514","volume":"72","author":"MA Martin-Serrano","year":"2023","unstructured":"Martin-Serrano, M. A. et al. Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications. Gut 72, 736\u2013748 (2023).","journal-title":"Gut"},{"key":"58429_CR34","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1126\/science.ade2292","volume":"381","author":"R Bill","year":"2023","unstructured":"Bill, R. et al. CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers. Science 381, 515\u2013524 (2023).","journal-title":"Science"},{"key":"58429_CR35","doi-asserted-by":"crossref","unstructured":"Wu, J. Y. et al. Cancer-derived succinate promotes macrophage polarization and cancer metastasis via succinate receptor. Mol. Cell. 77, 213\u2013227.e5 (2020).","DOI":"10.1016\/j.molcel.2019.10.023"},{"key":"58429_CR36","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.cmet.2022.02.002","volume":"34","author":"M Runtsch","year":"2022","unstructured":"Runtsch, M. et al. Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages. Cell Metab. 34, 487\u2013501.e488 (2022).","journal-title":"Cell Metab."},{"key":"58429_CR37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"L O\u2019Neill","year":"2016","unstructured":"O\u2019Neill, L., Kishton, R. & Rathmell, J. A guide to immunometabolism for immunologists. Nat. Rev. Immunol. 16, 553\u2013565 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"58429_CR38","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41422-020-0291-z","volume":"30","author":"E P\u00e5lsson-McDermott","year":"2020","unstructured":"P\u00e5lsson-McDermott, E. & O\u2019Neill, L. Targeting immunometabolism as an anti-inflammatory strategy. Cell Res. 30, 300\u2013314 (2020).","journal-title":"Cell Res."},{"key":"58429_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"N Pavlova","year":"2016","unstructured":"Pavlova, N. & Thompson, C. The emerging hallmarks of cancer metabolism. Cell Metab. 23, 27\u201347 (2016).","journal-title":"Cell Metab."},{"key":"58429_CR40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.molcel.2020.09.018","volume":"80","author":"Z Cai","year":"2020","unstructured":"Cai, Z. et al. Phosphorylation of PDHA by AMPK drives TCA cycle to promote cancer metastasis. Mol. Cell 80, 263\u2013278.e267 (2020).","journal-title":"Mol. Cell"},{"key":"58429_CR41","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.molcel.2016.02.009","volume":"61","author":"X Li","year":"2016","unstructured":"Li, X. et al. Mitochondria-translocated PGK1 functions as a protein kinase to coordinate glycolysis and the TCA cycle in tumorigenesis. Mol. Cell 61, 705\u2013719 (2016).","journal-title":"Mol. Cell"},{"key":"58429_CR42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/toxsci\/kfr333","volume":"126","author":"A Osman","year":"2012","unstructured":"Osman, A. & van Loveren, H. Phosphoproteomic analysis of mouse thymoma cells treated with tributyltin oxide: TBTO affects proliferation and energy sensing pathways. Toxicol. Sci. 126, 84\u2013100 (2012).","journal-title":"Toxicol. Sci."},{"key":"58429_CR43","doi-asserted-by":"crossref","unstructured":"Park, M. Y. et al. Scutellarein inhibits LPS-induced inflammation through NF-\u03baB\/MAPKs signaling pathway in RAW264.7 cells. Molecules. 27, 3782 (2022).","DOI":"10.3390\/molecules27123782"},{"key":"58429_CR44","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4049\/jimmunol.177.1.70","volume":"177","author":"Y Yao","year":"2006","unstructured":"Yao, Y. et al. ERK and p38 MAPK signaling pathways negatively regulate CIITA gene expression in dendritic cells and macrophages. J. Immunol. 177, 70\u201376 (2006).","journal-title":"J. Immunol."},{"key":"58429_CR45","doi-asserted-by":"publisher","first-page":"5054","DOI":"10.1182\/blood-2007-12-130609","volume":"111","author":"YC Chang","year":"2008","unstructured":"Chang, Y. C. et al. Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3. Blood 111, 5054\u20135063 (2008).","journal-title":"Blood"},{"key":"58429_CR46","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1172\/JCI78558","volume":"125","author":"P Grimm","year":"2015","unstructured":"Grimm, P. et al. Integrated compensatory network is activated in the absence of NCC phosphorylation. J. Clin. Investig. 125, 2136\u20132150 (2015).","journal-title":"J. Clin. Investig."},{"key":"58429_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.644797","volume":"8","author":"A Guerrero","year":"2021","unstructured":"Guerrero, A. et al. \u03b1-Ketoglutarate upregulates collecting duct (Pro)renin receptor expression, tubular angiotensin II formation, and Na(+) reabsorption during high glucose conditions. Front. Cardiovasc. Med. 8, 644797 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"58429_CR48","doi-asserted-by":"crossref","unstructured":"C\u00e1rdenas, P. et al. OXGR1-dependent (Pro)Renin receptor upregulation in collecting ducts of the clipped kidney contributes to Na(+) balance in goldblatt hypertensive mice. Int. J. Mol. Sci. 25, 10045 (2024).","DOI":"10.3390\/ijms251810045"},{"key":"58429_CR49","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41421-023-00570-y","volume":"9","author":"Y He","year":"2023","unstructured":"He, Y. et al. Lysine butyrylation of HSP90 regulated by KAT8 and HDAC11 confers chemoresistance. Cell Discov. 9, 74 (2023).","journal-title":"Cell Discov."},{"key":"58429_CR50","doi-asserted-by":"crossref","unstructured":"Ma, Q. et al. Acetyltransferase P300 regulates glucose metabolic reprogramming through catalyzing succinylation in lung cancer. Int. J. Mol. Sci. 25, 1057 (2024).","DOI":"10.3390\/ijms25021057"},{"key":"58429_CR51","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40170-021-00275-4","volume":"9","author":"NP Echeverri Ruiz","year":"2021","unstructured":"Echeverri Ruiz, N. P. et al. Dynamic regulation of mitochondrial pyruvate metabolism is necessary for orthotopic pancreatic tumor growth. Cancer Metab. 9, 39 (2021).","journal-title":"Cancer Metab."},{"key":"58429_CR52","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/jnc.13096","volume":"134","author":"GE Gibson","year":"2015","unstructured":"Gibson, G. E. et al. Alpha-ketoglutarate dehydrogenase complex-dependent succinylation of proteins in neurons and neuronal cell lines. J. Neurochem. 134, 86\u201396 (2015).","journal-title":"J. Neurochem."},{"key":"58429_CR53","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/jhbp.1219","volume":"30","author":"T Ioka","year":"2023","unstructured":"Ioka, T. et al. Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401- MITSUBA). J. Hepatobiliary Pancreat. Sci. 30, 102\u2013110 (2023).","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"58429_CR54","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","volume":"401","author":"RK Kelley","year":"2023","unstructured":"Kelley, R. K. et al. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 401, 1853\u20131865 (2023).","journal-title":"Lancet"},{"key":"58429_CR55","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41392-023-01317-7","volume":"8","author":"GM Shi","year":"2023","unstructured":"Shi, G. M. et al. Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study. Signal Transduct. Target. Ther. 8, 106 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"58429_CR56","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s00432-022-04166-z","volume":"149","author":"X Dong","year":"2023","unstructured":"Dong, X. et al. Triple therapy in biliary tract cancers: GemOX plus immune checkpoint inhibitor in combination with lenvatinib or NGS-guided targeted therapy. J. Cancer Res. Clin. Oncol. 149, 1917\u20131927 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"58429_CR57","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/annonc\/mdt540","volume":"25","author":"J Valle","year":"2014","unstructured":"Valle, J. et al. Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials. Ann. Oncol. 25, 391\u2013398 (2014).","journal-title":"Ann. Oncol."},{"key":"58429_CR58","doi-asserted-by":"crossref","unstructured":"Woods, E., Le, D., Jakka, B. K. & Manne, A. Changing landscape of systemic therapy in biliary tract cancer. Cancers. 14, 2137 (2022).","DOI":"10.3390\/cancers14092137"},{"key":"58429_CR59","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.6004\/jnccn.2014.0112","volume":"12","author":"AB Benson","year":"2014","unstructured":"Benson, A. B. et al. Hepatobiliary cancers, version 2.2014. J. Natl Compr. Canc Netw. 12, 1152\u20131182 (2014).","journal-title":"J. Natl Compr. Canc Netw."},{"key":"58429_CR60","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/S1470-2045(17)30314-5","volume":"18","author":"A Alistar","year":"2017","unstructured":"Alistar, A. et al. Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial. Lancet Oncol. 18, 770\u2013778 (2017).","journal-title":"Lancet Oncol."},{"key":"58429_CR61","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1158\/1078-0432.CCR-17-2282","volume":"24","author":"TS Pardee","year":"2018","unstructured":"Pardee, T. S. et al. A phase I study of CPI-613 in combination with high-dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia. Clin. Cancer Res. 24, 2060\u20132073 (2018).","journal-title":"Clin. Cancer Res."},{"key":"58429_CR62","doi-asserted-by":"publisher","first-page":"115713","DOI":"10.1016\/j.biopha.2023.115713","volume":"168","author":"Z Liu","year":"2023","unstructured":"Liu, Z., Wang, R., Wang, Y., Duan, Y. & Zhan, H. Targeting succinylation-mediated metabolic reprogramming as a potential approach for cancer therapy. Biomed. Pharmacother. 168, 115713 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"58429_CR63","first-page":"4683","volume":"11","author":"R Mu","year":"2021","unstructured":"Mu, R. et al. Role of succinylation modification in thyroid cancer and breast cancer. Am. J. Cancer Res. 11, 4683\u20134699 (2021).","journal-title":"Am. J. Cancer Res."},{"key":"58429_CR64","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1016\/j.molcel.2021.04.002","volume":"81","author":"Y Tong","year":"2021","unstructured":"Tong, Y. et al. SUCLA2-coupled regulation of GLS succinylation and activity counteracts oxidative stress in tumor cells. Mol. Cell 81, 2303\u20132316.e2308 (2021).","journal-title":"Mol. Cell"},{"key":"58429_CR65","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/ni.3796","volume":"18","author":"PS Liu","year":"2017","unstructured":"Liu, P. S. et al. \u03b1-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat. Immunol. 18, 985\u2013994 (2017).","journal-title":"Nat. Immunol."},{"key":"58429_CR66","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019103304","volume":"39","author":"Y Yuan","year":"2020","unstructured":"Yuan, Y. et al. Exercise-induced \u03b1-ketoglutaric acid stimulates muscle hypertrophy and fat loss through OXGR1-dependent adrenal activation. Embo J. 39, e103304 (2020).","journal-title":"Embo J."},{"key":"58429_CR67","doi-asserted-by":"crossref","unstructured":"Zeng, Y. R. et al. The immunometabolite itaconate stimulates OXGR1 to promote mucociliary clearance during the pulmonary innate immune response. J. Clin. Invest. 133 e160463 (2023).","DOI":"10.1172\/JCI160463"},{"key":"58429_CR68","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.2217\/fon-2019-0209","volume":"15","author":"PA Philip","year":"2019","unstructured":"Philip, P. A. et al. A phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas. Future Oncol. 15, 3189\u20133196 (2019).","journal-title":"Future Oncol."},{"key":"58429_CR69","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1158\/0008-5472.CAN-11-3596","volume":"72","author":"MR O\u2019Dell","year":"2012","unstructured":"O\u2019Dell, M. R. et al. Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma. Cancer Res. 72, 1557\u20131567 (2012).","journal-title":"Cancer Res."},{"key":"58429_CR70","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/sj.gt.3300947","volume":"6","author":"F Liu","year":"1999","unstructured":"Liu, F., Song, Y. & Liu, D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6, 1258\u20131266 (1999).","journal-title":"Gene Ther."},{"key":"58429_CR71","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt, J., Santos-Martins, D., Tillack, A. F. & Forli, S. AutoDock vina 1.2.0: new docking methods, expanded force field, and python bindings. J. Chem. Inf. Model. 61, 3891\u20133898 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"58429_CR72","doi-asserted-by":"publisher","first-page":"e1004586","DOI":"10.1371\/journal.pcbi.1004586","volume":"11","author":"PA Ravindranath","year":"2015","unstructured":"Ravindranath, P. A., Forli, S., Goodsell, D. S., Olson, A. J. & Sanner, M. F. AutoDockFR: advances in protein-ligand docking with explicitly specified binding site flexibility. PLoS Comput. Biol. 11, e1004586 (2015).","journal-title":"PLoS Comput. Biol."},{"key":"58429_CR73","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nprot.2011.335","volume":"6","author":"WB Dunn","year":"2011","unstructured":"Dunn, W. B. et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 6, 1060\u20131083 (2011).","journal-title":"Nat. Protoc."},{"key":"58429_CR74","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1021\/ac0713510","volume":"80","author":"S Wiklund","year":"2008","unstructured":"Wiklund, S. et al. Visualization of GC\/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal. Chem. 80, 115\u2013122 (2008).","journal-title":"Anal. Chem."},{"key":"58429_CR75","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/bit.10393","volume":"80","author":"WA van Winden","year":"2002","unstructured":"van Winden, W. A., Wittmann, C., Heinzle, E. & Heijnen, J. J. Correcting mass isotopomer distributions for naturally occurring isotopes. Biotechnol. Bioeng. 80, 477\u2013479 (2002).","journal-title":"Biotechnol. Bioeng."},{"key":"58429_CR76","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1093\/bioinformatics\/bts356","volume":"28","author":"L Wang","year":"2012","unstructured":"Wang, L., Wang, S. & Li, W. RSeQC: quality control of RNA-seq experiments. Bioinformatics 28, 2184\u20132185 (2012).","journal-title":"Bioinformatics"},{"key":"58429_CR77","doi-asserted-by":"publisher","first-page":"D258","DOI":"10.1093\/nar\/gkh036","volume":"32","author":"MA Harris","year":"2004","unstructured":"Harris, M. A. et al. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res. 32, D258\u2013D261 (2004).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58429-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58429-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58429-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T06:26:25Z","timestamp":1743834385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58429-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["58429"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-58429-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"2 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3177"}}